Studies related to C-Peptide and Chromium

In Patients With HIV-infection, Chromium Supplementation Improves Insulin Resistance And Other Metabolic Abnormalities: A Randomized, Double-blind, Placebo Controlled Trial

Effect None
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 46
Sex Both Genders
Age Range 18-29, 30-44
Notes for this study:
Supplementation of 400mcg chromium (as nicotinate) daily for 16 weeks in persons with HIV who were insulin resistant due to antiretroviral therapy appeared to improve insulin sensitivity and some other measured parameters such as triglycerides and weight when used as adjuvant.